The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,010.00
Bid: 12,008.00
Ask: 12,010.00
Change: -14.00 (-0.12%)
Spread: 2.00 (0.017%)
Open: 11,950.00
High: 12,142.00
Low: 11,944.00
Prev. Close: 12,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK virus cases highest since January with 58,000 new cases on Friday

Fri, 10th Dec 2021 19:03

(Alliance News) - The UK on Friday saw the highest number of Covid infections since January, a senior minister said Friday, as the government seeks to slow the spread of the new variant.

Communities Secretary Michael Gove said that the country faces a "deeply concerning situation" as the Omicron variant spreads rapidly, with case numbers doubling every two to three days in England.

The UK said it had a total of 58,194 cases on Friday. 

"We know that we have the highest number of Covid infections across the UK recorded today since January 9," when there were 59,937 cases, Gove told journalists after meeting leaders of UK regions.

He added that 30% of reported cases in London are now the Omicron variant, while the virus was only identified in the UK two weeks ago.

Scotland's First Minister Nicola Sturgeon warned that "we may be facing – indeed we may be starting to experience – a potential tsunami of infections".

The UK Health Security Agency said that if the trend continues, it expects Omicron to become the dominant variant in the UK by mid-December, with over one million infections by the end of this month. So far there have been 1,265 confirmed Omicron cases.

The UKHSA also said that early analysis of around 500 people confirmed to be infected with Omicron showed that AstraZeneca PLC and Pfizer Inc jabs "provided much lower levels of protection against symptomatic infection", in comparison to the Delta variant. 

A booster dose appeared to considerably increase this protection to between 70% and 75%, it said, while cautioning such small sample sizes should be treated with caution.

The UK has one of Europe's highest death tolls from the virus, at 146,255, while death rates have not risen in the last week.

Prime Minister Boris Johnson on Wednesday announced a range of tougher restrictions he called "Plan B", including compulsory mask-wearing in museums, theatres and cinemas from Friday and guidance to work from home from Monday. 

From Wednesday, people will have to show Covid passes with proof of two jabs or a lateral flow test in order to attend events in crowded settings such as nightclubs and stadiums.

The new regulations will be put to a debate and vote in the House of Commons next week but are expected to be approved despite opposition from some Tories.

source: AFP

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.